Ribociclib is approved for early-stage breast cancer in England, reducing the risk of recurrence by 29%.
© Baltimorechronicle.com. All rights reserved.
Tag:
Independent news platform delivering sharp analysis and fresh perspectives on USA, world affairs, politics, economy, tech, health, and more. Stay informed, stay ahead.